Clot Management Device Market Will Reach USD 2.01 Billion By 2032
Market Summary The global market for clot
management devices was valued at USD 1.26 billion in 2022 and is projected
to reach USD 2.01 billion by 2032, with a revenue compound annual growth rate
(CAGR) of 5.3% during the forecast period. Factors such as the increase in
minimally invasive surgical procedures, the prevalence of cardiovascular
diseases, and advancements in clot management device technology are driving the
growth of the market.
Cardiovascular diseases, including arterial thrombosis,
pulmonary embolism, and Deep Vein Thrombosis, are the leading cause of death
worldwide, contributing to 17.9 million fatalities annually, or 31% of all global
deaths. As clot management devices play a crucial role in treating and
preventing these disorders, the demand for such products is rising due to the
increasing prevalence of cardiovascular diseases, particularly among the aging
population.
Get a sample copy of the Clot
Management Device Market report: https://www.reportsanddata.com/download-free-sample/7920
The adoption of minimally invasive surgical techniques, such
as endovascular surgeries, is increasing due to their advantages over
traditional open surgeries, such as shorter hospital stays, quicker recovery
times, and fewer complications. Clot management devices are increasingly used
during these procedures to enhance the effectiveness and efficiency of clot
removal, thereby driving market growth.
Technological advancements in clot management devices,
including improved navigational systems and real-time monitoring capabilities,
are also contributing to market growth. Additionally, the development of more
effective devices aided by the discovery of novel materials like bioresorbable
polymers is fueling demand.
Factors such as rising obesity rates, sedentary lifestyles,
and diabetes further increase the demand for clot management devices and
elevate the risk of developing cardiovascular diseases.
However, market growth may be hindered by factors such as the
availability of alternative treatment options, high device costs, and limited
awareness of available treatment options. Additionally, the absence of
reimbursement regulations in developing countries may constrain revenue growth.
Key Government Regulations: Regulatory bodies like the U.S.
Food and Drug Administration (FDA), Centers for Medicare & Medicaid
Services (CMS), European Union (EU), and Canada's Medical Devices Bureau (MDB)
have established guidelines to ensure the safety and efficacy of clot management
devices.
Product Type Analysis: Mechanical thrombectomy devices are
expected to contribute significantly to market revenue, driven by their
increasing use in treating ischemic stroke. The emergence of advanced
mechanical thrombectomy devices capable of swift and effective clot removal is
expected to further propel market growth.
The segment for catheter-directed thrombolysis devices is
anticipated to witness substantial revenue growth, attributed to the rising
incidence of pulmonary embolism and deep vein thrombosis. Additionally, the
development of novel catheter-directed thrombolysis devices for faster and more
effective thrombolysis is expected to drive revenue growth.
Percutaneous thrombectomy devices are also expected to
experience rapid growth, primarily due to their frequent use in managing
peripheral arterial disease. The market is projected to expand further with the
increasing prevalence of peripheral arterial disease and the growing adoption
of minimally invasive therapies.
Application Outlook: The market for clot management devices
across applications such as peripheral artery disease, coronary artery disease,
and others is expected to grow rapidly in the coming years due to the rising
prevalence of cardiovascular diseases and an aging population.
A significant portion of market revenue is anticipated to
come from peripheral artery disease, driven by its increasing incidence and the
adoption of minimally invasive treatments. Similarly, the coronary artery
disease segment is expected to grow significantly, supported by advancements in
clot management tools.
Deep vein thrombosis and pulmonary embolism applications are
also projected to witness substantial growth, fueled by increasing disease
incidence and the development of advanced clot management devices.
Regional Outlook: North America accounted for the largest
share of the global clot management device market in 2022, with steady growth
expected during the forecast period. Factors contributing to this growth
include the high prevalence of cardiovascular diseases, government initiatives
to enhance healthcare, and investments in research and development by leading
manufacturers.
Europe is anticipated to experience significant growth due to
rising cardiovascular disease incidence, superior healthcare infrastructure,
and increasing adoption of advanced technology. In developing regions like Asia
Pacific, rapid market expansion is expected driven by rising healthcare
expenditure, growing awareness of cardiovascular diseases, and government
initiatives to improve healthcare infrastructure.
Competitive Landscape: Major companies operating in the
global clot management device market include Medtronic PLC, Penumbra, Inc.,
Boston Scientific Corporation, Johnson & Johnson, Stryker Corporation,
Teleflex Incorporated, Terumo Corporation, BTG International Ltd.,
AngioDynamics, Inc., and Acandis GmbH.
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/7920
Thank
you for reading our report. To know more about the customization or any query
about the report contents, please connect with us and our team will ensure the
report is tailored to meet your requirements.
About Reports and Data
Reports
and Data is a market research and consulting company that provides syndicated
research reports, customized research reports, and consulting services. Our
solutions purely focus on your purpose to locate, target, and analyse consumer
behaviour shifts across demographics, across industries, and help clients to
make smarter business decisions. We offer market intelligence studies ensuring
relevant and fact-based research across multiple industries, including
Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently
update our research offerings to ensure our clients are aware of the latest
trends existent in the market. Reports and Data has a strong base of
experienced analysts from varied areas of expertise. Our industry experience
and ability to develop a concrete solution to any research problems provides
our clients with the ability to secure an edge over their respective
competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse Latest Blogs: https://www.reportsanddata.com/blogs
Browse Latest Press
Release: https://www.reportsanddata.com/press-release
Comments
Post a Comment